Preferred Label : Semaglutide;

NCIt definition : A glucagon-like peptide-1 (GLP-1) receptor agonist that is 94% homologous to human GLP-1 (7-37), with antihyperglycemic and appetite regulating activities. Upon administration, semaglutide binds to and activates GLP-1 receptor. In pancreatic beta cells, this increases glucose-dependent insulin release. Semaglutide also reduces the elevated glucagon secretion by inhibiting alpha cells of the pancreas and slows gastric emptying. Altogether this lowers the postprandial glucose level. In the brain, the binding to and activation of GLP-1 receptor suppresses appetite, which decreases caloric intake and lowers body weight. GLP-1 is normally secreted by L cells of the gastrointestinal (GI) mucosa in response to a meal to normalize blood glucose levels. It also plays an important role in the regulation of appetite and caloric intake.;

UNII : 53AXN4NNHX;

InChIKey : DLSWIYLPEUIQAV-CCUURXOWSA-N;

CAS number : 910463-68-2;

Drug name : Ozempic; Wegovy; Rybelsus;

NCI Metathesaurus CUI : CL553532;

Details


Main resources

You can consult :


https://minerva-ebp.be/FR/Article/2387
2024
Belgium
critical appraisal or critical reading
obesity
adulthood
Usual Severity Weight Loss
Obese
semaglutide
How Much Distress Weight Loss
Weight Lifting
Illinois
How Often Weight Loss
weight loss
Semaglutide
Interleukin
weight loss
semaglutide
Weight Loss
Overweight
Israel
What Month is it
mouth, nos
adult
Oral Cavity
Oral Route of Administration
Oral Dosage Form
Legal Adult
Have Weight Loss
decreased body weight
overweight
Weight Loss, CTCAE

---
https://www.usherbrooke.ca/baladocritique/archives/episode-59-etude-select
2024
Canada
sound
Diastolic Blood Pressure
semaglutide
Obesity, CTCAE
Cardiovascular Disorder
data collection
Off Study
obesity
disease of cardiovascular system, nos
breeding
Clinical Study
semaglutide
obesity
Obesity
Have Diabetes
Human Participant Protection Regulations
DICOM Study
obesity, nos
cardiovascular diseases
diabetes mellitus
persons
Semaglutide
Obese
On Study

---
Nous contacter.
09/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.